SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-247739
Filing Date
2013-06-05
Accepted
2013-06-05 07:13:23
Documents
3
Period of Report
2013-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d550350d8k.htm 8-K 14190
2 EX-10.1 d550350dex101.htm EX-10.1 10110
3 GRAPHIC g550350g15n23.jpg GRAPHIC 295482
  Complete submission text file 0001193125-13-247739.txt   432670
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 13893110
SIC: 2836 Biological Products, (No Diagnostic Substances)